{
    "organizations": [],
    "uuid": "25da2d29099c9d9952e4f36b1d17b2d38e42aad3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cspc-pharmaceutical-groups-gastric/brief-cspc-pharmaceutical-groups-gastric-cancer-drug-granted-orphan-drug-designation-by-u-s-fda-idUSFWN1PW0HO",
    "ord_in_thread": 0,
    "title": "BRIEF-CSPC Pharmaceutical Group's Gastric Cancer Drug Granted Orphan-Drug Designation By U.S. FDA​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 6 (Reuters) - CSPC Pharmaceutical Group Ltd:\n* ‍GROUP‘S GASTRIC CANCER DRUG “DP303C” WAS GRANTED ORPHAN-DRUG DESIGNATION BY U.S. FDA​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-06T18:29:00.000+02:00",
    "crawled": "2018-02-07T21:53:03.029+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "cspc",
        "pharmaceutical",
        "group",
        "ltd",
        "gastric",
        "cancer",
        "drug",
        "dp303c",
        "granted",
        "designation",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}